Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

被引：0
|
作者：
C K Lee
R J Simes
C Brown
S Lord
U Wagner
M Plante
I Vergote
C Pisano
G Parma
A Burges
H Bourgeois
T Högberg
J Bentley
L Angleitner-Boubenizek
A Ferrero
B Richter
H Hirte
V Gebski
J Pfisterer
E Pujade-Lauraine
M Friedlander
机构：
[1] NHMRC Clinical Trials Centre,Department of Gynecology
[2] University of Sydney,Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology
[3] Gynecologic Endocrinology and Oncology,Division of Medical Oncology B
[4] University Hospital of Gießen and Marburg,Department of Gynecology and Obstetrics
[5] CHUQ- Hotel Dieu de Quebec,Department of Onco
[6] University Hospital Leuven,Hematology
[7] National Cancer Institute,Department of Gynaecologic Oncology
[8] Medical Gynecologic Oncology Unit,Academic Division of Gynecologic Oncology
[9] European Institute of Oncology,Department of Gynecology and Obstetrics
[10] Klinikum University of Munic,Department of Gynecology
[11] Campus Großhadern,undefined
[12] Centre Jean Bernard – SARL SORECOH,undefined
[13] Linkjoping University Hospital,undefined
[14] Dalhousie University,undefined
[15] 5820 University Avenue,undefined
[16] BHS Linz,undefined
[17] Seilerstätte 4,undefined
[18] Mauriziano Hospital,undefined
[19] University of Dresden,undefined
[20] Juravinski Cancer Centre at Hamilton Health Sciences,undefined
[21] Staedt. Klinikum Solingen,undefined
[22] Université Paris Descartes,undefined
[23] AP-HP,undefined
[24] Hôpitaux Universitaires Paris Centre,undefined
[25] Site Hôtel-Dieu,undefined
[26] Oncologie,undefined
[27] Prince of Wales Hospital,undefined
[28] Institute of Oncology,undefined
来源：
British Journal of Cancer | 2011年 / 105卷
关键词：
nomogram; recurrent ovarian cancer; prognosis; platinum sensitivity; progression-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1144 / 1150
页数：6
相关论文
共 50 条
  • [1] Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
    Lee, C. K.
    Simes, R. J.
    Brown, C.
    Lord, S.
    Wagner, U.
    Plante, M.
    Vergote, I.
    Pisano, C.
    Parma, G.
    Burges, A.
    Bourgeois, H.
    Hogberg, T.
    Bentley, J.
    Angleitner-Boubenizek, L.
    Ferrero, A.
    Richter, B.
    Hirte, H.
    Gebski, V.
    Pfisterer, J.
    Pujade-Lauraine, E.
    Friedlander, M.
    BRITISH JOURNAL OF CANCER, 2011, 105 (08) : 1144 - 1150
  • [2] Development of a nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer based on the CALYPSO trial
    Lee, C. K.
    Guardiola, E.
    Hogberg, T.
    Friedlander, M.
    Bentley, J.
    Denison, U.
    Vergote, I. B.
    Pisano, C.
    Parma, G.
    Wimberger, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer
    Lee, C. K.
    Simes, R. J.
    Brown, C.
    Gebski, V.
    Pfisterer, J.
    Swart, A. -M.
    Berton-Rigaud, D.
    Plante, M.
    Skeie-Jensen, T.
    Vergote, I.
    Schauer, C.
    Pisano, C.
    Parma, G.
    Baumann, K.
    Ledermann, J. A.
    Pujade-Lauraine, E.
    Bentley, J.
    Kristensen, G.
    Belau, A.
    Nankivell, M.
    Canzler, U.
    Lord, S. J.
    Kurzeder, C.
    Friedlander, M.
    ANNALS OF ONCOLOGY, 2013, 24 (04) : 937 - 943
  • [4] Atezolizumab does not improve progression-free survival in patients with recurrent platinum-sensitive ovarian cancer
    Gotlieb, Walter H.
    Tzur, Yossi
    GYNECOLOGY AND PELVIC MEDICINE, 2024, 7
  • [5] Atezolizumab does not improve progression-free survival in patients with recurrent platinum-sensitive ovarian cancer
    Gotlieb, Walter H.
    Tzur, Yossi
    GYNECOLOGY AND PELVIC MEDICINE, 2024, 7
  • [6] Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy
    Tjokrowidjaja, Angelina
    Friedlander, Michael
    Lord, Sarah J.
    Asher, Rebecca
    Rodrigues, Manuel
    Ledermann, Jonathan A.
    Matulonis, Ursula A.
    Oza, Amit M.
    Bruchim, Ilan
    Huzarski, Tomasz
    Gourley, Charlie
    Harter, Philipp
    Vergote, Ignace
    Scott, Clare L.
    Meier, Werner
    Shapira-Frommer, Ronnie
    Milenkova, Tsveta
    Pujade-Lauraine, Eric
    Gebski, Val
    Lee, Chee K.
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 190 - 200
  • [7] Impact of PARP inhibitors on progression-free survival in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective analysis
    Yumei Zhou
    Junfen Xu
    World Journal of Surgical Oncology, 22 (1)
  • [8] Platinum-free Interval May Predict Duration of Maintenance Bevacizumab and Survival in Platinum-sensitive Recurrent Ovarian Cancer
    Oh, Soo hyun
    Park, Soo jin
    Lee, Seungmee
    Lee, Seungho
    Kim, Hee seung
    IN VIVO, 2024, 38 (01): : 467 - 473
  • [9] A phase II, nonrandomized study of Abraxane plus carboplatin in patients with recurrent platinum-sensitive ovarian or primary peritoneal cancer: Evaluation of the response and survival and progression-free survival
    Housseini, A. A.
    Sofidiya, M.
    Daugherty, P.
    Benigno, B.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S129 - S130
  • [10] Development of a nomogram to predict the progression-free survival in lung cancer patients
    Tafenzi, H. A.
    Choulli, F.
    Baladi, A.
    El Fadli, M.
    Essadi, I.
    Belbaraka, R.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S155 - S155
12345